TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.
Mol Pharm
; 17(6): 2109-2124, 2020 06 01.
Article
in En
| MEDLINE
| ID: mdl-32383885
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Killer Cells, Natural
/
Toll-Like Receptor 7
/
Toll-Like Receptor 8
/
Nanoparticles
/
Immunotherapy
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2020
Type:
Article
Affiliation country:
United States